Patent details
88854 Product Name: Doxorubicine liposomale pegylée, éventuellement sous forme de sel à usage pharmaceutique.
Basic Information
- Publication number:
- 88854
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP919005132
- Legal Status:
- Expired
- Application number:
- 88854
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/96/011/001+002
- Marketing Authorization Type:
- Marketing Authorization Date:
- 21/06/1996
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 13/12/1996
- First Marketing Authorization date:
- 21/06/1996
- Grant date:
- 11/03/1997
- Activation date:
- 19/10/2010
- Publication date:
- 11/03/1997
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 21/06/2011
- SPC Extension Expiration:
- 21/06/2011
- Rejection date:
- Withdrawal date:
Owner
- From:
- 13/12/1996
- Name:
- SEQUUS PHARMACEUTICALS INC. (A DELAWARE CORPORATION)
- Address:
- HAMILTON COURT 960, 94025, MENLO PARK, CA, United States (US)
Agent
1
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 14/05/1997
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
2
- Name:
- PRONOVEM LUXEMBOURG
- From:
- 13/12/1996
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
- 13/05/1997
| Filing date | Document type | Number of pages |
|---|